Scott Tanner

Scott Tanner is an accomplished finance professional with extensive experience in accounting and financial management. Currently serving as Senior Director, Controller at Candid Therapeutics since October 2024, Scott previously held the position of Director, Finance & Accounting at CG Oncology from May to October 2024. Prior to these roles, Scott spent over 15 years at EY in various capacities, including Senior Manager in Transactional and Technical Topics (T3) focusing on share-based payments and as Assurance Senior Manager. Scott began their career with EY as an Assurance Intern in 2007. Scott Tanner earned a Bachelor of Business Administration (BBA) in Accountancy from the University of San Diego in 2008.